- PARADIGM ™ program comprises two 12-week randomized, placebo-controlled studies (APPROACH and EMBRACE) and a long-term extension study (EXTEND) - - EXTEND: a Phase III Open Label Extension Study ...

Paradigm, a specialty care management organization focused on delivering value-based solutions to improve outcomes for patients, payers, and providers, today announced that My Surgery has been ...

Paradigm and Film2Future have inked a two-year collaborative agreement that will see the talent agency become the exclusive partner of the non-profit that promotes pathways into the entertainment ...

Paradigm would like to report to its shareholders that there are currently 839,680,555 outstanding shares, unchanged from our last report. The company has made significant progress over the course of ...

Le Bonheur Children's Hospital's risk-based innovation program Changing High-Risk Asthma in Memphis through Partnership (CHAMP) has significantly decreased health care use related to asthma by ...

Paradigm has started the work program on the Navarro County Properties under the Joint Venture Oil Production Program agreement the company recently entered into and announced on March 21, 2011.

New Paradigm Investment, an accelerator fostering innovative startups, announced on the 3rd that it is recruiting innovative startups eligible to receive up to 5 billion won through the '2025 first ...

SAN FRANCISCO--(BUSINESS WIRE)--Homeward ®, a company committed to rearchitecting the delivery of health and care in partnership with communities everywhere, starting in rural America, today announced ...

“Just three years after filing an Investigational New Drug application for CYB003, the initiation of our Phase 3 program is a truly significant and gratifying milestone,” said ...